Hess, Urs

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 12.

Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672

Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; ... (2020). Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 4(15), pp. 3699-3707. American Society of Hematology 10.1182/bloodadvances.2020002160

Schnegg-Kaufmann, Annatina; Feller, Anita; Baldomero, Helen; Rovó, Alicia; Manz, Markus G; Gregor, Michael; Efthymiou, Anna; Bargetzi, Mario; Hess, Urs; Spertini, Olivier; Chalandon, Yves; Passweg, Jakob R; Stussi, Georg; Arndt, Volker; Bonadies, Nicolas (2018). Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Cancer epidemiology, 52, pp. 55-62. Elsevier 10.1016/j.canep.2017.11.008

Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Baerlocher, Gabriela M.; Bargetzi, Mario; Chalandon, Yves; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Halter, Jörg P; Heim, Dominik; Hess, Urs; Leibundgut, Kurt; Masouridi-Levrat, Stavroula; Müller, Antonia; Nair, Gayathri; Pabst, Thomas; Renner, Christoph; Schmidt, Adrian; Stussi, Georg; ... (2018). Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Swiss medical weekly, 148(w14589), w14589. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14589

Baumgartner, Annic; Bargetzi, Mario; Bargetzi, Annika; Zueger, Noemi; Medinger, Micheal; Passweg, Jakob; Schanz, Urs; Samaras, Panagiotis; Chalandon, Yves; Pichard, Claude; Limonta, Alessandro; Wannesson, Luciano; Pabst, Thomas; Duchosal, Michel A; Hess, Urs; Stanga, Zeno; Mueller, Beat; Schuetz, Philipp (2017). Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition, 35, pp. 43-50. Elsevier 10.1016/j.nut.2016.10.007

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss medical weekly, 145, w14100. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14100

Passweg, Jakob R; Baldomero, Helen; Bargetzi, Mario; Bucher, Christoph; Chalandon, Yves; Duchosal, Michel A; Gratwohl, Alois; Güngör, Tayfun; Hess, Urs; Leibundgut, Kurt; de Faveri, Grazia Nicoloso; Ozsahin, Hulya; Pabst, Thomas; Renner, Christoph; Stern, Martin; Stussi, Georg; Schanz, Urs; SBST (Swiss Blood Stem Cell Transplantation Group), (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss medical weekly, 143, w13757. Muttenz: EMH Schweizerischer Ärzteverlag

Wannesson, Luciano; Bargetzi, Mario; Cairoli, Anne; Cerutti, Alessandra; Heim, Dominik; Hess, Urs; Lerch, Erika; Pabst, Thomas; Renner, Christoph; Samaras, Panagiotis; Zucca, Emanuele (2013). Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone). Leukemia & lymphoma, 54(1), pp. 36-40. London: Informa Healthcare 10.3109/10428194.2012.702903

Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Utiger, Urs; Cerny, Thomas; Hess, Urs; Bassi, Simona; Okkinga, Emmie; Stupp, Roger; Stahel, Rolf; Heizmann, Marc; Vorobiof, Daniel; Lohri, Andreas; Dietrich, Pierre-Yves; Zucca, Emanuele; Ghielmini, Michele (2010). Long Term Follow-Up Of Patients With Follicular Lymphoma Receiving Single Agent Rituximab At Two Different Schedules In Trial SAKK 35/98. Journal of clinical oncology, 28(29), pp. 4480-4484. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.28.4786

Zenhäusern, Reinhard; Von Rohr, Albert; Rufibach, Kaspar; Solenthaler, Max; Meyer-Monard, Sandrine; Gratwohl, Alois; Hess, Urs; Bargetzi, Mario J; Kovacsovic, Tibor; Leoncini, Leda; Tobler, Andreas (2009). Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95. Leukemia & lymphoma, 50(1), pp. 133-6. London: Informa Healthcare 10.1080/10428190802527681

Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Martinelli, Giovanni; Peccatori, F; Hess, Urs; Fey, Martin; Zucca, Emanuele; Stahel, Rolf; Ketterer, Nicolas; Cerny, Thomas (2009). Long-term follow-up of patients with follicular lymphoma (FL) receiving single agent rituximab at two different schedules in study SAKK 35/98. Journal of clinical oncology, 27(15), p. 8512. American Society of Clinical Oncology

Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Hess, Urs; Okkinga, Emmie; Stupp, Roger; Taverna, Christian; Vorobiof, Daniel; Heizman, Marc; Dietrich, Pierre-Yves; Ghielmini, Michele (2009). Long-term follow-up of follicular lymphoma (FL) patients receiving single agent rituximab at two different schedules in trial SAKK 35/98. European journal of cancer, 7(2), p. 562. Elsevier 10.1016/S1359-6349(09)71897-X

This list was generated on Thu Nov 21 11:58:31 2024 CET.
Provide Feedback